PRESS RELEASE

Filter by date
Sep 2018

Sebia Capillarys 3 TERA is now connected to Inpeco FlexLab automation

The FlexLab connection with Capillarys 3 TERA TLA represents another step ahead in the TLA expansion, opening new opportunities for Lab Automation and bringing the most popular capillary electrophoresis analyzer closer to the core clinical laboratory workflow.

Download PDF
Mar 2018

Sebia launches new-generation serum free light chain (sFLC) assays for multiple myeloma testing

New test assays improve analytics and clinical coherence for the diagnosis and monitoring of multiple myeloma

Download PDF
Jan 2018

Sebia announces FDA clearance for its Hydrashift 2/4 daratumumab assay

The in vitro diagnostic test, developed in collaboration with Janssen, allows for assessment of response in patients with multiple myeloma by mitigating potential interference induced by daratumumab

Download PDF
Jan 2017

Sebia signs agreement with Janssen Biotech to develop a multiple myeloma IVD test

Test allows for clear results of multiple myeloma patients’ response by eliminating potential interference induced by novel therapeutic antibody

Download PDF
Jun 2016

Sebia and Abingdon Health sign exclusive global distribution agreement

Sebia will distribute worldwide Seralite®-FLC serum lateral flow immunoassays for the diagnosis and monitoring of multiple myeloma

Download PDF
Mar 2016

Sebia HbA1c assay now has CE mark for diagnosis of diabetes

Sebia HbA1c assay now has CE mark for diagnosis of diabetes

Download PDF
Jun 2015

Sebia brings to market new Capillarys 3 Tera with CE mark

Sebia brings to market new Capillarys 3 Tera automated system with CE mark HbA1c and serum protein testing, and immunotyping

Download PDF
Jul 2014

Hemoglobins Atlas

This comprehensive new medical compendium commemorates ten years of Sebia’s excellence in the field of hemoglobin separation using capillary electrophoresis

Download PDF
Nov 2011

New HbA1c diabetes diagnostic technology from Sebia

New HbA1c diabetes diagnostic technology from Sebia will help laboratories facing the fast changing environment of diabetes assessment

Download PDF